Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma. Reply

Thomas Powles, Laurence Albiges, Brian Rini

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

langue originale	Anglais
Pages (de - à)	2062-2063
Nombre de pages	2
journal	New England Journal of Medicine
Volume	391
Numéro de publication	21
Les DOIs	https://doi.org/10.1056/NEJMc2411843
état	Publié - 28 nov. 2024

Accès au document

@article{584b36a2856d4f23b153fb556439ae0c,

title = "Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma. Reply",

author = "Thomas Powles and Laurence Albiges and Brian Rini",

year = "2024",

month = nov,

day = "28",

doi = "10.1056/NEJMc2411843",

language = "English",

volume = "391",

pages = "2062--2063",

journal = "New England Journal of Medicine",

issn = "0028-4793",

number = "21",

}

TY - JOUR

T1 - Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma. Reply

AU - Powles, Thomas

AU - Albiges, Laurence

AU - Rini, Brian

PY - 2024/11/28

Y1 - 2024/11/28

UR - http://www.scopus.com/inward/record.url?scp=85211017180&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2411843

DO - 10.1056/NEJMc2411843

M3 - Letter

C2 - 39602645

AN - SCOPUS:85211017180

SN - 0028-4793

VL - 391

SP - 2062

EP - 2063

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 21

ER -